Laboratorios Farmaceuticos Rovi, S.A. (BME:ROVI)
59.05
+0.10 (0.17%)
May 18, 2026, 4:24 PM CET
BME:ROVI Revenue
Laboratorios Farmaceuticos Rovi had revenue of 152.49M EUR in the quarter ending March 31, 2026, a decrease of -1.55%. This brings the company's revenue in the last twelve months to 741.09M, down -3.44% year-over-year. In the year 2025, Laboratorios Farmaceuticos Rovi had annual revenue of 743.48M, down -2.65%.
Revenue (ttm)
741.09M
Revenue Growth
-3.44%
P/S Ratio
4.07
Revenue / Employee
370.91K
Employees
2,045
Market Cap
3.02B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 743.48M | -20.27M | -2.65% |
| Dec 31, 2024 | 763.75M | -65.76M | -7.93% |
| Dec 31, 2023 | 829.51M | 11.81M | 1.44% |
| Dec 31, 2022 | 817.70M | 169.02M | 26.06% |
| Dec 31, 2021 | 648.68M | 228.72M | 54.46% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Grifols | 7.44B |
| Almirall | 1.12B |
| Faes Farma | 674.06M |
| Laboratorio Reig Jofre | 335.01M |
| Clínica Baviera | 304.91M |
| Prim, S.A. | 251.89M |
| Pharma Mar | 225.43M |
| Atrys Health | 144.31M |
Laboratorios Farmaceuticos Rovi News
- 10 days ago - Laboratorios Farmaceuticos Rovi SA (WBO:ROVI) Q1 2026 Earnings Call Highlights: Navigating ... - GuruFocus
- 10 days ago - Q1 2026 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript - GuruFocus
- 12 days ago - Laboratorios Farmaceuticos Rovi Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - Laboratorios Farmaceuticos Rovi SA (STU:41L) Q4 2025 Earnings Call Highlights: Strategic Growth ... - GuruFocus
- 2 months ago - Q4 2025 Laboratorios Farmaceuticos ROVI SA Earnings Call Transcript - GuruFocus
- 2 months ago - Laboratorios Farmaceuticos Rovi Earnings Call Transcript: Q4 2025 - Transcripts
- 8 months ago - Laboratorios Farmaceuticos Rovi Transcript: Investor Update - Transcripts
- 10 months ago - Laboratorios Farmaceuticos Rovi Earnings Call Transcript: Q2 2025 - Transcripts